UCBJF : Summary for UCB NPV - Yahoo Finance

U.S. Markets open in 5 hrs 24 mins

UCB S.A. (UCBJF)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
62.87-3.38 (-5.10%)
At close: 12:06 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close66.25
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume845
Market Cap11.84B
Beta-0.22
PE Ratio (TTM)17.26
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.27 (1.91%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Amgen Presents Osteoporosis Data; Parsabiv Approved in EU
    Zacks23 days ago

    Amgen Presents Osteoporosis Data; Parsabiv Approved in EU

    Amgen, Inc. (AMGN) and partner UCB S.A. (UCBJF) announced results from the pivotal phase III BRIDGE study which showed that its pipeline candidate, romosozumab, significantly increases bone mineral density in men with osteoporosis.

  • Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2
    Zackslast month

    Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2

    Dr. Reddy's Laboratories Ltd. (RDY) reported second-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 27 cents, down 57.1% year over year.

  • UCB SA – Value Analysis (US OTC:UCBJF) : September 28, 2016
    Capital Cube2 months ago

    UCB SA – Value Analysis (US OTC:UCBJF) : September 28, 2016

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives UCB SA a score of 41. Our analysis is based on comparing UCB SA with the following peers – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc., Catalyst Pharmaceuticals, Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US, CPRX-US and NVS-US). Investment Outlook UCB ... Read more (Read more...)